Luminus Management LLC Aslan Pharmaceuticals LTD Transaction History

Luminus Management LLC

  • $211 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$2.5 - $3.72 $4.38 Million - $6.52 Million
-1,753,800 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$1.86 - $5.25 $3.26 Million - $9.21 Million
1,753,800 New
1,753,800 $5.88 Million

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About ASLAN Pharmaceuticals Ltd

ASLN Quotes by TradingView
  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $157M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Luminus Management LLC Portfolio

Follow Luminus Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Luminus Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Luminus Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email